Mental Health Research Center, Mood Disorders Research Group, Iran University of Medical Sciences, Tehran, Iran.
Clinical Psychology Department, School of Behavioral Sciences and Mental Health (Tehran Psychiatry Institute), Mental Health Research Center, Iran University of Medical Sciences, Tehran, Iran.
Brain Behav. 2021 May;11(5):e01894. doi: 10.1002/brb3.1894. Epub 2021 Mar 17.
The purpose of this study was to evaluate the psychometric properties of Structured Clinical Interview Version for DSM-5 (R) Clinical Version (SCID-5-CV) in a population of patients with psychiatric disorders in Tehran.
The study population included all outpatients and inpatients referred to three psychiatric centers in Tehran, namely Iran Psychiatric Hospital, Rasoul Akram Hospital, and Clinic of Behavioral Sciences and Mental Health (Tehran Psychiatric Institute). Inclusion criteria included age between 16 and 70 years, informed consent to study, ability to understand and speak Persian, and no specific physical problems that interfere with the conduct of the interview. Also, exclusion criteria included inability to communicate, mental retardation or dementia, severe symptoms of acute psychosis, and severe restlessness. In addition to demographic questionnaire, Persian version of SCID-5-CV was used in this study. Finally, diagnostic validity, test-retest reliability, and inter-rater reliability were used to evaluate the information.
In terms of the kappa criterion, for all diagnoses except for anxiety disorders, kappa was above 0.4 as a result of agreement above average, but in anxiety disorders with kappa 0.34 there was a moderate agreement between psychiatrist and SCID interviewer reports. Also, according to the psychiatrist's diagnosis as the gold standard, in most diagnoses, except for anxiety disorders, kappa was higher than 0.80, indicating the desirable characteristic of this tool in the diagnosis of disorders. Sensitivity of all diagnoses was higher than 0.80.
According to the findings of the present study, SCID-5-CV can be used for diagnostic purposes in psychiatric clinics and hospitals and to evaluate the treatment process of patients. In general, this version is suitable especially the schizophrenia spectrum and other psychiatric disorders; however, using SCID-5-CV for anxiety-related disorders should be done with caution.
本研究旨在评估 DSM-5 临床定式访谈版（SCID-5-CV）在德黑兰精神障碍患者人群中的心理测量特性。
研究人群包括所有转诊至德黑兰三家精神病中心的门诊和住院患者，即伊朗精神病院、拉索尔阿克拉姆医院和行为科学与心理健康诊所（德黑兰心理研究所）。纳入标准包括年龄在 16 至 70 岁之间、同意参加研究、能够理解和讲波斯语、以及没有具体的身体问题干扰访谈进行。此外，排除标准包括无法沟通、智力障碍或痴呆、严重的急性精神病症状和严重的不安。除了人口统计学问卷外，本研究还使用了波斯语版的 SCID-5-CV。最后，使用诊断有效性、测试重测信度和评分者间信度来评估信息。
根据kappa 标准，除了焦虑障碍外，所有诊断的kappa 值均高于 0.4，表明两者之间的一致性高于平均水平，但在焦虑障碍中kappa 值为 0.34，表明精神科医生和 SCID 访谈员报告之间存在中度一致性。此外，根据精神科医生的诊断作为金标准，除了焦虑障碍外，大多数诊断的kappa 值均高于 0.80，表明该工具在诊断障碍方面具有理想的特征。所有诊断的敏感性均高于 0.80。
根据本研究的结果，SCID-5-CV 可用于精神病诊所和医院的诊断目的，并评估患者的治疗过程。总的来说，该版本特别适用于精神分裂症谱系和其他精神障碍；然而，在评估与焦虑相关的障碍时，应谨慎使用 SCID-5-CV。
